503a semaglutide Microdose Out of Shortage, Into Controversy:

& Thoo, L

The newer STEP UP trial in 2025 looked at the higher 7.2mg dose and found average weight loss of 21% over 72 weeks

Research into the cell-level mechanisms of IGF1 LR3 action has used advanced techniques including gene expression profiling, proteomics, and metabolomics

These findings are not surprising, Mir Ali, MD, a bariatric surgeon, bariatric medicine specialist and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, told Medical News Today

"The TGA advises that the product 'Lercea GLP-1 Multi-Action Ampoules' is not included in the Australian Register of Therapeutic Goods and has not been approved by the TGA for supply in Australia," the spokesperson said

This injection is popular among active individuals, athletes, busy professionals and wellness focused clients who want efficient support for strength, stamina and recovery without scheduling a full IV infusion